Health Care

CVS Health Corporation (CVS) on Tuesday reported second-quarter earnings of $1.27 billion.

Mylan lowered the bar for shareholder approval in its ongoing hostile bid for rival pharmaceutical company Perrigo.

Global Blood Therapeutics shares surged Wednesday after the blood disorder drug developer's initial public offering raised $120 million, more than it had expected.

Early research in older adults found an experimental vaccine prevented nearly two-thirds of serious cases of a common, seasonal respiratory virus that annually kills thousands of vulnerable people — babies and senior citizens.

Amarin Corporation has won an early victory in federal court against the Food and Drug Administration over the right to promote unapproved uses of its prescription fish-oil pill.

Allergan PLC (AGN) on Thursday reported a second-quarter loss of $243.1 million, after reporting a profit in the same period a year earlier.

IBM says it will pay $1 billion to acquire medical imaging and software company Merge Healthcare, part of an effort to boost the health care capabilities of Watson, its cognitive computing system.

Irish drugmaker Shire PLC Is offering to buy Baxalta Inc. for about $30 billion in stock in a move to solidify its position in rare disease treatments.

Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE Tyson Foods Inc., down $4.39 to $39.96 The meat producer reported worse-than-expected fiscal third-quarter profit and cut its outlook, citing high cattle costs.

Relatives of an Ohio woman who died after being sent home from a hospital while having a heart attack have reached a $275,000 settlement with the facility.

Shares of MannKind stumbled Thursday after the French pharmaceutical giant Sanofi detailed low initial sales for a fast-acting, inhaled insulin developed by MannKind.

Anglo-Swedish drug firm AstraZeneca says second-quarter net income fell 12 percent to $697 million as competition from generic drug companies reduced sales.

Britain-based drugmaker GlaxoSmithKline has reported a drop in earnings in the first full quarter since its deal to swap some assets with Swiss rival Novartis.

Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE Teva Pharmaceuticals Industries Ltd., up $10.15 to $72 The generic drugmaker is buying Allergan's generic pharmaceuticals business for $40.5 billion, expanding its industry position.

Pfizer Inc. (PFE) on Tuesday reported second-quarter net income of $2.63 billion.

Merck & Co. (MRK) on Tuesday reported second-quarter profit of $687 million.

French drugmaker Sanofi said Monday it will pay up to $300 million to buy a thyroid cancer drug from British competitor AstraZeneca.

Israel's Teva Pharmaceutical Industries Ltd. says it is purchasing Dublin-based Allergan PLC's generic pharmaceuticals business for $40.5 billion.

A doctor who serves as mayor of a northern New Jersey town pleaded not guilty Monday to charges that he took cash bribes and other kickbacks for referring patients to a medical imaging company.